CEO: Paul B. Bolno

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: WAVE Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.


Key numbers

Market Capitalization:982751400
Shares Outstanding: 34290000
Float: 27923958.630000003
Next Earning Date:2020-03-16
TTm EPS: -5.346
TTm Dividend Rate:
200 days moving average:28.07
50 days moving average: 23.29
One day percent Change: 5.97



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,